ICU Medical, Inc. (ICUI) vs Tango Therapeutics, Inc. (TNGX)
A side-by-side comparison of ICU Medical, Inc. and Tango Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ICUI
ICU Medical, Inc.
$159.73HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TNGX
Tango Therapeutics, Inc.
$21.88HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — ICUI vs TNGX
growth of $100 · dividends reinvested · last 6yICUI -18.5% (-3.3%/yr)TNGX +125.6% (+14.5%/yr)TNGX compounded faster over this window
ICUI TNGX
ICUI vs TNGX: by the numbers
- •ICUI is the larger company ($3.99B vs $3.56B market cap).
- •ICUI is profitable (1.39% net margin) while TNGX runs a net loss (-229.92%).
- •TNGX grew revenue faster over the past five years (19.14% vs 11.05% CAGR).
Metrics side by side
Valuation
| Metric | ICUI | TNGX |
|---|---|---|
| P/E ratio | 135.36 | N/A |
| P/S ratio | 1.85 | 66.19 |
| P/B ratio | 1.86 | 3.48 |
| EV / EBITDA | 13.66 | N/A |
| FCF yield | 3.83% | N/A |
Profitability
| Metric | ICUI | TNGX |
|---|---|---|
| Gross margin | 37.56% | 98.25% |
| Operating margin | 5.04% | -178.39% |
| Net margin | 1.39% | -229.92% |
| ROE | 1.40% | -12.08% |
| ROIC | 3.11% | -12.91% |
Growth (annualized)
| Metric | ICUI | TNGX |
|---|---|---|
| Revenue CAGR (5Y) | 11.05% | 19.14% |
| EPS CAGR (5Y) | -62.79% | N/A |
| FCF CAGR (5Y) | -2.65% | N/A |
| Total return CAGR (5Y) | -7.18% | 10.60% |
Frequently asked
- Which has grown faster, ICUI or TNGX?
- Over the past five years, TNGX grew revenue faster — ICUI at a 11.05% CAGR versus TNGX at 19.14%.
- Is ICUI or TNGX more profitable?
- ICUI runs the higher net margin — ICUI at 1.39% versus TNGX at -229.92%.
- How have ICUI and TNGX total returns compared?
- Over the past 5 years, ICUI delivered -7.18% and TNGX delivered 10.60% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ICU Medical P/E ratioICU Medical ROETango Therapeutics ROEICU Medical operating marginTango Therapeutics operating marginICU Medical revenue growthTango Therapeutics revenue growthICU Medical free cash flowTango Therapeutics free cash flow
ICU Medical & Tango Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.